Treatment of syphilis with azithromycin
- 1 January 1996
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 7 (1_suppl), 13-15
- https://doi.org/10.1258/0956462961917249
Abstract
The efficacy of oral azithromycin (500 mg daily for 10 days or 500 mg on alternate days for 11 days) in 100 patients with seropositive syphilis was studied. Clinical manifestations regressed more rapidly in azithromycin-treated patients compared with patients who received erythromycin or penicillin, and there was also a more rapid reduction in serum antibody levels. In 90.3% of patients, the complete resolution of classic serological tests was observed within 4 months of completion of the azithromycin treatment. The immobilization (TPI) test and absorbed fluorescent treponema antibody tests became negative 12 months after treatment in 40% of patients. After 4 years of follow-up, no symptoms of neurosyphilis or syphilitic changes of visceral organs were observed.Keywords
This publication has 7 references indexed in Scilit:
- Single Dose Azithromycin for the Treatment of ChancroidSexually Transmitted Diseases, 1994
- Multicenter Trial of Single-Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated GonorrheaSexually Transmitted Diseases, 1994
- Advances in the antimicrobial therapy of chlamydial genital infectionsJournal of Infection, 1992
- Efficacy of azithromycin for therapy of active syphilis in the rabbit modelJournal of Antimicrobial Chemotherapy, 1990
- The pharmacokinetics of azithromycin in human serum and tissuesJournal of Antimicrobial Chemotherapy, 1990
- In-vitro activity of azithromycin and CP-63,956 against Treponema pallidumJournal of Antimicrobial Chemotherapy, 1990
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989